A detailed history of Royal London Asset Management LTD transactions in Viatris Inc stock. As of the latest transaction made, Royal London Asset Management LTD holds 500,380 shares of VTRS stock, worth $6.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
500,380
Previous 507,580 1.42%
Holding current value
$6.2 Million
Previous $5.4 Million 7.67%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.32 - $12.13 $74,304 - $87,336
-7,200 Reduced 1.42%
500,380 $5.81 Million
Q1 2024

May 14, 2024

SELL
$11.27 - $13.53 $70,403 - $84,521
-6,247 Reduced 1.22%
507,580 $6.06 Million
Q4 2023

Feb 13, 2024

BUY
$8.77 - $10.85 $416,311 - $515,049
47,470 Added 10.18%
513,827 $5.56 Million
Q3 2023

Nov 14, 2023

BUY
$9.59 - $11.35 $464,779 - $550,077
48,465 Added 11.6%
466,357 $4.6 Million
Q1 2023

May 15, 2023

SELL
$9.2 - $12.26 $54,151 - $72,162
-5,886 Reduced 1.39%
417,892 $4.02 Million
Q3 2022

Nov 14, 2022

SELL
$8.48 - $11.13 $342,295 - $449,262
-40,365 Reduced 8.7%
423,778 $3.61 Million
Q2 2022

Aug 12, 2022

SELL
$9.95 - $12.27 $48,446 - $59,742
-4,869 Reduced 1.04%
464,143 $4.86 Million
Q1 2022

May 13, 2022

BUY
$9.81 - $15.4 $196,739 - $308,847
20,055 Added 4.47%
469,012 $5.1 Million
Q4 2021

Oct 18, 2022

SELL
$12.09 - $14.68 $80,978 - $98,326
-6,698 Reduced 1.47%
448,957 $6.08 Million
Q4 2021

Jan 18, 2022

SELL
$12.09 - $14.68 $80,978 - $98,326
-6,698 Reduced 1.47%
448,957 $6.08 Million
Q2 2021

Oct 18, 2022

SELL
$12.97 - $16.15 $110,089 - $137,081
-8,488 Reduced 1.83%
455,655 $6.51 Million
Q1 2021

Oct 17, 2022

SELL
$13.59 - $18.54 $115,351 - $157,367
-8,488 Reduced 1.83%
455,655 $6.37 Million
Q1 2021

Apr 13, 2021

BUY
$13.59 - $18.54 $243,804 - $332,607
17,940 Added 4.1%
455,655 $6.37 Million
Q4 2020

Jan 29, 2021

BUY
$14.3 - $18.74 $6.26 Million - $8.2 Million
437,715 New
437,715 $8.2 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Royal London Asset Management LTD Portfolio

Follow Royal London Asset Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Royal London Asset Management LTD with notifications on news.